Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      AiMeD welcomes Delhi govt steps to cap profit margins of hospitals on medical devices

      AiMeD welcomes Delhi govt steps to cap profit margins of hospitals on medical devices

      Medical Dialogues Bureau11 May 2018 10:56 AM IST
      New Delhi: The Association of Indian Medical Device Industry (AiMeD) today lauded the Delhi government for working on capping profit margins of...
      Sanofi India net moves up by 37.5% in Q1, Charles Billard will be new CFO

      Sanofi India net moves up by 37.5% in Q1, Charles Billard will be new CFO

      Medical Dialogues Bureau11 May 2018 9:56 AM IST
      New Delhi: Drug firm Sanofi India on Tuesday reported 37.27 per cent rise in net profit to Rs 82.5 crore for the quarter ended March 31, 2018.The...
      Daiichi-Ranbaxy row: HC allows sale of Singh brothers firms

      Daiichi-Ranbaxy row: HC allows sale of Singh brothers' firms

      Medical Dialogues Bureau10 May 2018 4:51 PM IST
      New Delhi: The Delhi High Court today allowed the sale of unencumbered shares of the firms of former promoters of India's Ranbaxy Laboratories Ltd in...
      Suven secures product patents in Australia, Eurasia and Europe

      Suven secures product patents in Australia, Eurasia and Europe

      Medical Dialogues Bureau10 May 2018 4:51 PM IST
      New Delhi: Suven Life Sciences today said it has been granted a product patent by Australia, Eurasia and Europe corresponding to a new chemical entity...
      Drugmaker GSK rings in more change as CFO heads for exit in 2019

      Drugmaker GSK rings in more change as CFO heads for exit in 2019

      Medical Dialogues Bureau10 May 2018 4:51 PM IST
      LONDON - Glaxo Smith Kline Plc, Britain's biggest drugmaker, faces more top management change with Chief Financial Officer Simon Dingemans set to...
      Fortis board members deny allegations made by 2 institutional shareholders

      Fortis board members deny allegations made by 2 institutional shareholders

      Medical Dialogues Bureau10 May 2018 4:48 PM IST
      New Delhi: Fortis Healthcare's four directors, whose removal has been sought by two institutional shareholders, have denied allegations that they...
      Strides Shasun, Apotex to merge Australian operations

      Strides Shasun, Apotex to merge Australian operations

      Medical Dialogues Bureau10 May 2018 9:45 AM IST
      New Delhi: Drug firm Strides Shasun today said it has agreed in principle with Canada's Apotex to merge their business operations in Australia.The...
      Seized from Delhi: Prohibited drugs including Alprazolam, Diazepam Worth Rs 10 crore

      Seized from Delhi: Prohibited drugs including Alprazolam, Diazepam Worth Rs 10 crore

      Medical Dialogues Bureau9 May 2018 11:30 AM IST
      New Delhi: The DRI has seized huge quantity of prohibited drugs like Alprazolam and Diazepam among others worth Rs 10 crore from the Foreign Post...
      Japanese drug maker Takeda to buy Irelands Shire

      Japanese drug maker Takeda to buy Ireland's Shire

      Medical Dialogues Bureau9 May 2018 11:28 AM IST
      TOKYO: Japanese drugmaker Takeda has agreed to buy Shire for 46 billion pounds ($62.4 billion) in cash and stock, one of the biggest deals ever in the...
      Granules India gets USFDA nod for muscle pain tablets

      Granules India gets USFDA nod for muscle pain tablets

      Medical Dialogues Bureau9 May 2018 11:27 AM IST
      NEW DELHI: Granules India has received approval from the US health regulator for generic Methocarbamol tablets in two strengths used for the treatment...
      Valeant Pharma reports quarterly loss, to change name to Bausch Health

      Valeant Pharma reports quarterly loss, to change name to Bausch Health

      Medical Dialogues Bureau9 May 2018 9:27 AM IST
      Valeant Pharmaceuticals International Inc reported first-quarter loss compared with a year-ago profit and said on Tuesday it would change its name to...
      Expansion of pharmaceutical unit; HC notice to Puducherry govt

      Expansion of pharmaceutical unit; HC notice to Puducherry govt

      Medical Dialogues Bureau8 May 2018 11:28 AM IST
      Chennai: The Madras High Court has issued notice to the Puducherry government on a PIL seeking direction to halt the proposed expansion of a...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok